Xenothera
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Xenothera Patents
Xenothera has filed 2 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- Experimental cancer drugs
- Immunology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/15/2015 | 8/15/2023 | Immune system, Immunology, Clusters of differentiation, Proteins, Cell biology | Grant |
Application Date | 10/15/2015 |
|---|---|
Grant Date | 8/15/2023 |
Title | |
Related Topics | Immune system, Immunology, Clusters of differentiation, Proteins, Cell biology |
Status | Grant |
Latest Xenothera News
May 30, 2023
NANTES, France--(BUSINESS WIRE)-- #ASCO23--At the ASCO congress, the French biotech XENOTHERA details the properties of its fourth GH-pAb, XON7, active against solid tumors and in hematology.
Xenothera Frequently Asked Questions (FAQ)
When was Xenothera founded?
Xenothera was founded in 2014.
Where is Xenothera's headquarters?
Xenothera's headquarters is located at 1 rue Vauban, Nantes.
What is Xenothera's latest funding round?
Xenothera's latest funding round is Unattributed.
How much did Xenothera raise?
Xenothera raised a total of $39.14M.
Who are the investors of Xenothera?
Investors of Xenothera include Pays De La Loire Development, Atlantique Business Angels Booster, Malakoff Humanis, Nabuboto, Pays De La Loire Participations and 10 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
